Возраст домена | n/a |
Дата окончания | n/a |
PR | 3 |
ИКС | 10 |
Страниц в Google | 871 |
Страниц в Яндексе | 373 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 2458169 |
Alexa Country | 1151346 |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
PACE-CME - Education, innovation, policy in cardiovascular medicine
n/a
Education, innovation, policy in cardiovascular medicine
UTF-8
153.47 КБ
610
5 059 симв.
4 186 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
nih.gov | 15 | 8 |
0 | 113 | 65 | |
medscape.com | 9 | 7 |
0 | 2705 | 1296 | |
uptodate.com | 7 | 7 |
0 | 3860 | 1200 | |
nature.com | 6 | 9 |
0 | 740 | 269 | |
wikipedia.org | 5 | 9 |
0 | 5 | 6 | |
theheart.org | 5 | 6 |
40 | 11568406 | Нет данных | |
biomedcentral.com | 4 | 8 |
0 | 3615 | 3079 | |
ahajournals.org | 3 | 6 |
0 | 22579 | 12273 | |
medscape.org | 3 | 7 |
40 | 59228 | 24555 | |
clinicaltrialresults.org | 3 | 4 |
0 | 3137488 | Нет данных | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Внутренние ссылки главной страницы ( 116 ) | |
/ | pace-cme.org |
/browse/?k=CALENDAR&s=DATE_ASC | Agenda |
/browse/?k=TOPIC&m=COMPACT&s=TITLE_ASC | Topics ▼ |
/browse/ | More |
/browse/?k=COURSE&s=DATE_DESC | Online-CME |
/browse/?k=NEWS | News ▼ |
/browse/?k=MEETING_REPORT | Meeting Reports |
/browse/?k=SLIDES | Slides ▼ |
/about/ | About |
/browse/?search=true | <img> |
/2019/03/15/acc-19/ | ACC.19 ▼ |
/2019/11/12/aha-2019/ | AHA 2019 ▼ |
/diabetes-cvd/ | Diabetes & CVD ▼ |
/2019/06/03/eas-2019/ | EAS 2019 ▼ |
/2019/08/31/esc-2019/ | ESC 2019 ▼ |
/esc-diabetes-guidelines-2019/ | ESC Diabetes guidelines 2019 |
/esc-eas-guidelines-dyslipidaemias-2019/ | ESC/EAS Guidelines dyslipidaemias 2019 |
/hfpef-the-essentials-to-know/ | HFpEF: The essentials to know |
/1970/01/01/ldl-c-expert-meeting/ | LDL-c Expert Meeting ▼ |
/ldl-c-key-lessons/ | LDL-c Key Lessons ▼ |
/pcsk9/ | PCSK9 |
/2019/12/19/efficacy-and-safety-of-arni-in-high-risk-patient... | Efficacy and safety of ARNI in high-risk patients in the PIONEER-HF trial5' education - Dec. 19, 2019 - Prof. David Morrow, MD i... |
/2019/12/17/accumulating-and-convincing-evidence-points-at-t... | Accumulating and convincing evidence points at triglycerides being an important CV risk factor10' education - Dec. 17, 2019 - Pr... |
/2019/12/17/fda-approves-new-indication-for-icosapent-ethyl-... | FDA approves new indication for icosapent ethyl in high CV risk patients News - Dec. 17, 2019 |
/2019/12/11/paradigm-hf-and-paragon-hf-redefining-hfref-and-... | PARADIGM-HF and PARAGON-HF: Redefining HFrEF and HFpEF10' education - Dec. 11, 2019 - Milton Packer, MD if image end if image |
/2019/12/09/effect-of-bet-inhibition-on-cv-outcomes-in-acs-a... | Effect of BET inhibition on CV outcomes in ACS and diabetes patients10' education - Dec. 9, 2019 - Prof. Kausik Ray, MD if image... |
/2019/12/02/new-tool-can-help-identify-fh-patients/ | New tool can help identify FH patients3' education - Nov. 17, 2019 - Willem Bax, Alkmaar - AHA 2019, Philadelphia if image end i... |
/2019/11/25/improved-health-status-with-sglt2-inhibitor-in-h... | Improved health status with SGLT2-inhibitor in HFrEF3' education - Nov. 25, 2019 - Prof. Mikhail Kosiborod - AHA 2019, Philadelp... |
/2019/11/25/a-rise-in-adverse-clinical-events-with-noac-regi... | A rise in adverse clinical events with NOAC-regime after TAVR resulted in termination of trial 3' education - Nov. 25, 2019 - Pr... |
/2019/11/25/possible-favorable-effects-of-icosapent-ethyl-on... | Possible favorable effects of icosapent ethyl on plaque-parameters3' education - Nov. 25, 2019 - Prof. Stephen Nicholls - AHA 20... |
/2019/11/25/single-dose-colchicine-prior-to-pci-reduces-rise... | Single dose colchicine prior to PCI reduces rise in inflammation, but does not give reduction in MI and MACE3' education - Nov. ... |
/2019/11/18/more-evidence-that-aspirin-may-not-be-necessary-... | if scroller_items_image end if scroller_items_image More evidence that aspirin may not be necessary in long-term antiplatelet th... |
/2019/11/18/is-hf-the-same-disease-across-the-ef-spectrum-or... | if scroller_items_image end if scroller_items_image Is HF the same disease across the EF spectrum, or does HF have two physiolog... |
/2019/11/18/arni-seems-to-give-cv-benefit-not-only-in-hfref-... | if scroller_items_image end if scroller_items_image ARNI seems to give CV benefit not only in HFrEF, but up to EF of about 60%3'... |
/2019/11/18/fish-oil-treatment-reduces-several-plaque-parame... | if scroller_items_image end if scroller_items_image Fish oil treatment reduces several plaque parameters after 9 months3' educat... |
/2019/11/18/benefit-on-qol-with-revascularization-proportion... | if scroller_items_image end if scroller_items_image Benefit on QoL with revascularization proportional to severity of angina sym... |
/2019/11/18/patients-with-moderate-ischemia-on-a-stress-test... | if scroller_items_image end if scroller_items_image Patients with moderate ischemia on a stress test do not need to go straight ... |
/2019/11/17/invasive-vs-conservative-strategy-does-not-reduc... | if scroller_items_image end if scroller_items_image Invasive vs. conservative strategy does not reduce CV events in patients wit... |
/2019/11/16/succesful-repurposing-of-an-old-anti-inflammator... | Succesful repurposing of an old anti-inflammatory drug for a new application3' education - Nov. 16, 2019 - Aruna Pradhan, MD - A... |
/2019/11/16/new-generation-of-teenagers-made-addicted-to-nic... | if scroller_items_image end if scroller_items_image New generation of teenagers made addicted to nicotine: it is time to act3' e... |
/2019/11/16/treatment-with-anti-inflammatory-agent-reduces-b... | Treatment with anti-inflammatory agent reduces both first and recurrent events post-MI3' education - Nov. 16, 2019 - Jean-Claude... |
/2019/11/16/pcsk9-sirna-on-top-of-maximally-tolerated-statin... | PCSK9 siRNA, on top of maximally tolerated statin therapy, potently lowers LDL-c 3' education - Nov. 16, 2019 - R. Scott Wright,... |
/2019/12/10/meta-analysis-of-the-efficacy-of-the-dapt-score-... | Meta-analysis of the efficacy of the DAPT score to decide on treatment duration Literature - Dec. 10, 2019 - Witberg G et al., ... |
/2019/12/10/new-screening-tool-uses-machine-learning-to-iden... | New screening tool uses machine learning to identify individuals with probable FH in large datasetsLiterature - Dec. 10, 2019 - ... |
/2019/12/09/previously-unknown-af-prevalent-but-af-burden-lo... | Previously unknown AF prevalent, but AF burden low in at-risk elderly persons with implanted loop recorder Literature - Dec. 9, ... |
/2019/12/03/broader-definition-using-clinical-probability-an... | Broader definition using clinical probability and D-dimer identifies more subjects with low PE risk Literature - Dec. 3, 2019 - ... |
/2019/12/02/effect-of-noac-vs-vka-on-clinical-outcomes-in-af... | Effect of NOAC vs. VKA on clinical outcomes in AF patients independent of burden of comorbidities Literature - Dec. 2, 2019 - Ni... |
/2019/12/02/recent-hospitalizations-for-hf-may-identify-hfpe... | Recent hospitalizations for HF may identify HFpEF at higher risk that may benefit from ARNILiterature - Dec. 2, 2019 - Vaduganat... |
/2019/10/21/mechanisms-of-action-of-glp-1ras/ | Mechanisms of action of GLP-1RAs10' education - Oct. 21, 2019 - Prof. Filip Knop, MD if image end if image |
/2019/10/21/glp-1ra-where-do-they-fit-in-cv-risk-management/ | GLP-1RA: where do they fit in CV risk management?10' education - Oct. 21, 2019 - Prof. John Deanfield, MD if right_section_items... |
/1970/01/01/5-things-a-cardiologist-should-know-about-diabet... | 5 Things a cardiologist should know about diabetes |
/2018/07/24/slide-curriculum-diabetes-and-cardiology/ | Slide Curriculum: Diabetes and cardiologySlides (curriculum) - July 24, 2018 if image end if image |
/2018/03/29/pace-special-5-things-a-cardiologist-should-know... | PACE Special: 5 Things a cardiologist should know about diabetesDownload - Download your free copy if image end if image |
/2018/03/29/hypoglycemia-in-cardiovascular-medicine-why-worr... | Hypoglycemia in cardiovascular medicine: why worry?10' education - Mar. 7, 2018 - Prof Guntram Schernthaner - Vienna, Austria -... |
/acs/ | ACS |
/2019/11/18/oral-load-of-colchicine-prior-to-pci-prevents-a-... | Oral load of colchicine prior to PCI prevents a rise of inflammatory biomarkers in acute injuryNews - Nov. 18, 2019 |
/2019/10/30/identification-of-parameters-associated-with-pla... | Identification of parameters associated with plaque erosion in STEMI and NSTE-ACSLiterature - Oct. 30, 2019 - Yamamoto E et al.,... |
/atherosclerosis/ | Atherosclerosis |
/2019/11/18/interim-data-study-into-effects-of-fish-oil-on-p... | Interim data study into effects of fish oil on plaque progression shows promising findingsNews - Nov. 18, 2019 |
/2019/10/29/long-term-safety-and-ldl-lowering-with-pcsk9-inh... | Long-term safety and LDL lowering with PCSK9 inhibition in hypercholesterolemic patientsLiterature - Oct. 29, 2019 - Koren MJ et... |
/atrial-fibrillation/ | Atrial fibrillation |
/2019/11/07/rate-trends-and-predictors-of-early-mortality-af... | Rate, trends and predictors of early mortality after AF ablationLiterature - Nov. 7, 2019 - Cheng EP, et al. - J Am Coll Cardiol... |
/2019/10/29/lower-risk-of-osteoporotic-fractures-in-af-patie... | Lower risk of osteoporotic fractures in AF patients with DOAC vs. VKA treatmentLiterature - Oct. 29, 2019 - Binding C, et al. - ... |
/cv-inflammation/ | CV Inflammation |
/cvrm/ | CVRM |
/2019/11/04/persons-with-nafld-are-not-automatically-at-high... | Persons with NAFLD are not automatically at high risk of acute MI or strokeLiterature - Nov. 4, 2019 - Alexander M et al, - BMJ... |
/2019/10/14/not-only-weight-loss-but-also-maintaining-a-lowe... | Not only weight loss, but also maintaining a lower weight is important for a good CV risk profileLiterature - Oct. 14, 2019 - Be... |
/2019/10/10/parental-smoking-increases-af-risk-in-offspring/ | Parental smoking increases AF risk in offspring Literature - Oct. 10, 2019 - Groh CA et al., - J Am Coll Cardiol 2019 |
/diabetes/ | Diabetes |
/2019/11/17/bet-inhibitor-therapy-did-not-meet-primary-endpo... | BET inhibitor therapy did not meet primary endpoint of reducing MACE in post-ACS patients with T2DMNews - Nov. 17, 2019 |
/epigenetics-in-cvd/ | Epigenetics in CVD |
/2019/10/02/clinical-update-on-bet-inhibition-the-patient-pr... | Clinical update on BET inhibition: The patient profile that may benefit from BET inhibition10' education - Aug. 31, 2019 - Prof.... |
/2019/10/07/slides-2019-esc-guidelines-on-diabetes-pre-diabe... | Slides: 2019 ESC guidelines on diabetes, pre-diabetes and cardiovascular diseases - Expert insights and rationale Slides (presen... |
/2019/09/30/the-2019-esc-easd-diabetes-guidelines-a-major-pa... | The 2019 ESC/EASD diabetes guidelines: a major paradigm shift in the management of T2DM10' education - Sep. 30, 2019 - Paris, Fr... |
/2019/09/03/new-esc-easd-guidelines-on-diabetes-no-longer-re... | New ESC/EASD Guidelines on diabetes no longer regard metformin as first-line therapyNews - Sep. 3, 2019 if image end if image |
/2019/10/04/ldl-c-targets-in-the-esc-eas-dyslipidaemia-guide... | LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshell10' education - Oct. 4, 2019 - Prof. Brian Ference, MD if ima... |
/2019/09/09/slides-ldl-c-targets-in-the-esc-eas-dyslipidaemi... | Slides: LDL-c targets in the ESC/EAS dyslipidaemia guidelines in a nutshellSlides (presentation) - Sep. 9, 2019 - ESC Paris, Fra... |
/2019/09/09/rationale-for-the-lower-ldl-c-targets-in-the-201... | Rationale for the lower LDL-c targets in the 2019 ESC/EAS Dyslipidemia Guidelines5' education - Sep. 9, 2019 - Paris, France - P... |
/2018/03/22/expert-meeting-glp-1-cvd-t2dm/ | Expert Meeting GLP-1, CVD & T2DM |
/2018/06/19/translation-of-novel-approaches-in-cvd-diabetes-... | Translation of novel approaches in CVD & diabetes to clinical practice10' education - Mar. 22, 2018 - John Deanfield, Francesco ... |
/2018/06/05/novel-diabetes-drugs-in-clinical-management-exte... | Novel diabetes drugs in clinical management: Extending the opportunities10' education - June 5, 2018 - Stefano Taddei, Cees Tack... |
/2018/05/15/clinical-trials-in-diabetes-and-cvd-what-did-we-... | Clinical trials in diabetes and CVD: What did we learn?10' education - Mar. 22, 2018 - Filippo Crea, Angelyn Bethel, Eduard Mont... |
/familial-hypercholesterolemia/ | Familial Hypercholesterolemia |
/glp-1-ra-cvd/ | GLP-1 RA & CVD |
/2019/10/22/subgroup-analyses-in-glp1-ra-trial-meta-analysis... | Subgroup analyses in GLP1-RA trial meta-analysis to understand the varying outcomes seen with different GLP-1RAsLiterature - Oct... |
/2019/10/04/the-diabetes-challenge-for-cardiologists-the-key... | The diabetes challenge for cardiologists: The key things to understand10' education - Sep. 2, 2019 - Prof. Naveed Sattar, MD if ... |
/heart-failure/ | Heart Failure |
/2018/11/27/hfpef-current-and-future-clinical-approaches-to-... | HFpEF: Current and future clinical approaches to manage HFpEF10' education - Aug. 27, 2018 - Burkert Pieske, MD - Berlin, German... |
/2018/11/07/slides-hfpef-what-are-the-most-likely-pathophysi... | Slides: HFpEF: What are the most likely pathophysiological mechanisms involved in the disease Slides (presentation) - Aug. 27, 2... |
/2018/11/07/hfpef-how-to-diagnose/ | HFpEF: How to diagnose10' education - Aug. 27, 2018 - Barry Borlaug - Rochester, MN, USA - Online CME if image end if image |
/hypertension/ | Hypertension |
/2019/11/12/thiazide-or-thiazide-like-diuretics-superior-to-... | Thiazide or thiazide-like diuretics superior to ACEi as initial monotherapy in hypertensionLiterature - Nov. 12, 2019 - Suchard ... |
/2019/10/31/hypertension-medication-ingestion-at-bedtime-imp... | Hypertension medication ingestion at bedtime improves asleep ABP and reduces CVD riskLiterature - Oct. 31, 2019 - Hermida RC et ... |
/2019/10/24/biochemical-urine-test-to-measure-medical-adhere... | Biochemical urine test to measure medical adherence in hypertension5' education - Oct. 24, 2019 - Paris, France - Dan Lane if im... |
/inflammation-expert-opinions/ | Inflammation Expert Opinions |
/2017/10/27/ultime-notizie-sulla-terapia-un-farmaco-anti-inf... | Ultime notizie sulla terapia: Un farmaco anti-infiammatorio riduce eventi cardiovascolari maggiori5' education - Aug. 27, 2017 -... |
/2017/10/27/breakthrough-therapy-anti-inflammatory-drug-can-... | Breakthrough therapy: Anti-inflammatory drug can affect important CV outcomes5' education - Aug. 27, 2017 - ESC 2017, Barcelona,... |
/2017/10/23/clinical-implications-of-inhibiting-inflammation... | Clinical implications of inhibiting inflammation as risk factor for progression of CVD5' education - Aug. 27, 2017 if image end ... |
/invest-in-your-arteries/ | Invest in your arteries |
/2018/06/26/estimating-cv-risk-and-treatment-benefit/ | Estimating CV risk and treatment benefit10' education - June 12, 2018 - Prof. Frank Visseren - Utrecht, The Netherlands - Online... |
/2018/06/19/importance-of-hypertension-in-cvd-prevention/ | Importance of hypertension in CVD prevention10' education - June 12, 2018 - Prof. Richard Hobbs - Oxford, UK - Online CME if im... |
/2018/06/06/the-role-of-lipids-in-cvd-prevention-lessons-lea... | The role of lipids in CVD prevention: Lessons learned about statins10' education - June 6, 2018 - Prof. Kees Hovingh - Amsterdam... |
/lipids/ | Lipids |
/2019/11/25/ldl-c-target-of-70-vs-100-mg-ml-after-stroke-low... | LDL-c target of News - Nov. 25, 2019 |
/lp-a/ | Lp(a) |
/2019/09/28/insights-and-lessons-from-the-odyssey-outcomes-t... | Insights and lessons from the ODYSSEY Outcomes trial: Which patients benefit most?10' education - Sep. 28, 2019 - Paris, France ... |
/2019/09/16/high-lp-a-levels-associate-with-mortality-throug... | High Lp(a) levels associate with mortality, through low number of Kringle-IV type 2 repeatsLiterature - Sep. 16, 2019 - Langsted... |
/2019/09/01/new-esc-eas-dyslipidemia-guidelines-advocate-low... | New ESC/EAS dyslipidemia guidelines advocate “lower is better” for LDL-c News - Sep. 1, 2019 if image end if image |
/2019/11/16/potent-and-durable-ldl-c-lowering-up-to-18-month... | Potent and durable LDL-c lowering up to 18 months with siRNA against PCSK9 News - Nov. 16, 2019 |
/pulmonary-arterial-hypertension/ | Pulmonary Arterial Hypertension |
/2018/05/31/pulmonary-arterial-hypertension-key-questions-ad... | Pulmonary Arterial Hypertension: Key questions addressedOnline-CME - This course consists of 3 separate lectures if image end if... |
/2018/05/30/why-cardiologists-should-be-more-interested-in-p... | Why cardiologists should be more interested in PAH3' education - Mar. 9, 2018 - VBWG at ACC, Orlando, FL, USA - Prof. Mardi Gomb... |
/2017/11/28/novel-insights-in-the-management-and-prognosis-o... | Novel insights in the management and prognosis of pulmonary hypertension5' education - Aug. 29, 2017 - ESC 2017, Barcelona, Spai... |
/stroke/ | Stroke |
/2019/10/10/optimism-associated-with-reduced-risk-of-cv-even... | Optimism associated with reduced risk of CV events and all-cause mortality Literature - Oct. 10, 2019 - Rozanski A, et al. - JAM... |
/2019/09/10/long-term-treatment-with-dual-antiplatelet-thera... | Long-term treatment with dual antiplatelet therapy in patients with diabetes and stable CAD3' education - Sep. 9, 2019 - Prof. P... |
[Querying whois.publicinterestregistry.net]
[whois.publicinterestregistry.net]
WHOIS LIMIT EXCEEDED - SEE WWW.PIR.ORG/WHOIS FOR DETAILS
Sitemap: https://pace-cme.org/sitemap.txt
User-agent: *
Allow: /
США - 208.109.91.122
GoDaddy.com, LLC
GoDaddy.com, LLC
HTTP/1.1 200 OK
Server: nginx
Date: Fri, 27 Dec 2019 04:10:12 GMT
Content-Type: text/html
Transfer-Encoding: chunked
Connection: keep-alive
Expires: Fri, 27 Dec 2019 04:12:12 GMT
Cache-Control: max-age=120
Cache-Control: public
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"